Möchten Sie immer auf dem neuesten Stand bleiben?

Q1 2026 total revenue of $22.7 million including neffy® (epinephrine nasal spray) U.S. net product revenue of $17.5 million CVS Caremark proposal in final stages of approval process; definitive...

– On track to report initial safety, PK and early activity from Phase 1 dose-escalation trial of STRO-004, potential best-in-class Tissue Factor ADC, in mid-2026 – – Continued advancement of...

Sangamo Therapeutics reports first quarter 2026 business updates and financial results

Manufacturing operations divestiture sharpens focus on core capabilities in novel drug discovery and developmentManufacturing divestiture and expanded monetization of ZYNYZ royalty anticipated to...

ETOBICOKE, Ontario, May 12, 2026 (GLOBE NEWSWIRE) -- Cleanfarms, Canada’s not-for-profit producer responsibility organization that focuses on agricultural plastics recovery and recycling, released...

Austin, TX, USA, May 11, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Flexible Endoscope Market Size, Trends and Insights By Product (Bronchoscopes,...

Jazz announced U.S. FDA acceptance with Priority Review of Supplemental Biologics License Application (sBLA) for zanidatamab in first-line HER2-positive unresectable locally advanced or metastatic...

Increased 2026 revenue guidance from $510 million to $525 million Achieved record-high quarterly revenues, Adjusted EBITDA1 and Adjusted EBITDA per share1 since inception MONTREAL, May 07, 2026 ...

First Quarter 2026 Revenues of $371.0 Million Reflect 22.6 Percent Growth and 15.8 Percent Organic Growth Over First Quarter 2025 Revenues of $302.6 Million Unmanned Systems First Quarter 2026...

Dupixent showed significant and clinically meaningful improvements in both esophageal distensibility as well as disease-related structural changes and inflammation in the esophagus in adult patients...